ISNI

ASNI Neuroimmunology Seminar Series
2021-06-24 18:00 - 19:00 (Europe/Rome) | Virtual ASNI
Title:Neuroimmunology of psychiatric disorders
With
Anna Molofsky (University of California, San Francisco, USA) & Jerika Barron (Molofky Lab)
Moderators
Dana McTigue (The Ohio State University, USA) & Tajie Harris (University of Virginia, USA)

Neuroimmunology Australia Webinar Series
2021-06-25 22:00 - 23:00, 2021-07-30 22:00 - 23:00, 2021-08-27 22:00 - 23:00 (Europe/Rome) | Virtual Neuroimmunology Australia

ESNI Journal Club
2021-06-29 15:00 - 16:00 (Europe/Rome) | Virtual ESNI
Title: Distinct amyloid-β and tau-associated microglia profiles in Alzheimer’s disease

With
Emma Gerrits & Bart Eggen (University of Groningen, Netherlands)
Presenting
Anouk Benmamar-Badel (University of Southern Denmark – Odense, Denmark)
Moderator
Maja Jagodic (Karolinska Institutet – Stockholm, Sweden)

Advances in Neuroimmunology: Promise for Novel Therapeutics for CNS Disorders
2021-06-30 15:00 - 17:30 (Europe/Rome) | Virtual JNI
On 30 June 2021, Johnson & Johnson Innovation will host a virtual scientific event on state-of-the-art developments in neuroimmunology, bringing together entrepreneurs, start-ups, researchers, and scientists from across Europe and beyond.
The successes of therapeutics targeting inflammatory mechanisms in relapsing and remitting multiple sclerosis have led to neuroimmunology emerging as an important new paradigm in central nervous system (CNS) disorders.1 In neurodegenerative disorders like Alzheimer’s disease and Parkinson’s disease, human disease genetics strongly implicate several inflammatory pathways such as microglial signaling and complement.2 Moreover, recent research implicates inflammation in psychiatric disorders such as schizophrenia and major depressive disorder.3
The field holds great promise for the development of impactful novel therapeutics to treat several CNS disorders of high unmet medical need. Current challenges focus on generating robust therapeutic hypotheses for neuroinflammatory disorders, patient stratification and drug discovery challenges to develop safe CNS penetrant molecules. However, new data emerging from advanced genomics and big data analytics is helping the field better understand the challenges and navigate the roles of various inflammatory processes in several CNS indications. This research is bolstered by exciting findings from human cell and preclinical transgenic models, enabling further detailed understanding of disease biology.
While past pharmaceutical company investment has been thwarted by the complexities of CNS disorders, a vibrant investor environment is now supporting exciting new companies with drug discovery programmes for a range of neuroimmunology targets. Given the advances in this field, Johnson & Johnson Innovation, in collaboration with Janssen Neuroscience, is seeking to gather industry-leading entrepreneurs, biotechs and academic researchers for a discussion on harnessing the next wave of science and innovation in neuroimmunology.
1Dobson and Giovannoni Eur J Neurol. 2019 26: 27-40
2Crehan et al. 2012. Int J Alzheimer Dis doi: 10.1155/2012/983640
3 Bauer and Teixeira 2021 Neuroimmunomodulation doi: 10.1159/000515594

ASNI Neuroimmunology Seminar Series
2021-07-29 18:00 - 19:00 (Europe/Rome) | Virtual ASNI
Title: Under the influence – B cells, the microbiome, and CNS inflammation
With
Jennifer Gommerman (University of Toronto, Canada) & Valeria Ramaglia (Gommerman’s Lab)
Moderators
Amit Bar-Or (University of Pennsylvania (UPenn), USA) & Rajiv Jain (University of Calgary, Canada)

ASNI Neuroimmunology Seminar Series
2021-08-26 18:00 - 19:00 (Europe/Rome) | Virtual ASNI
Title: Neuroimmunology of stroke and dementia
With
Constantino Iadecola (Weill Cornell Medicine, USA) & Monica Santisteban (Iadecola’s Lab)
Moderators
Sunghee Cho (Weill Cornell Medicine/Burke Neurological Institute, USA) & Maya Koronyo-Hamaoui (Cedars-Sinai Medical Center Los Angeles, USA)

ESNI Journal Club
2021-08-31 15:00 - 16:00 (Europe/Rome) | Virtual ESNI
Title:Identifying CNS-colonizing T cells as potential therapeutic targets to prevent progression of multiple sclerosis

With
Manuel A. Friese & Max Kaufmann (University Medical Centre Hamburg-Eppendorf, Germany)
Presenting
Milica Lazarević (University of Belgrade, Serbia)
Moderator
Maja Jagodic (Karolinska Institutet – Stockholm, Sweden)

7th European Stroke Organisation Conference (ESOC 2021)
2021-09-01 - 2021-09-03 | Virtual ESOC

Lipid Mediators in Brain Diseases
2021-09-09 - 2021-09-10 | Hasselt University, Belgium
Download flyer here

XXIX AINI Congress
2021-09-16 - 2021-09-19 | Hotel Leon d’Oro, Viale del Piave, 5, Verona, 37135, Italy

ESNI Journal Club
2021-09-28 15:00 - 16:00 (Europe/Rome) | Virtual ESNI
Title: Gut microbiota–specific IgA+ B cells traffic to the CNS in active multiple sclerosis

With
Anne-Katrin Pröbstel (University of Basel, Switzerland)
Presenting
Sinduya Krishnarajah (University of Zürich, Switzerland)
Moderator
Maja Jagodic (Karolinska Institutet – Stockholm, Sweden)

ASNI Neuroimmunology Seminar Series
2021-09-30 18:00 - 19:00 (Europe/Rome) | Virtual ASNI
Title: The myeloid side of the brain
With
Marco Prinz (University of Freibrug, Germany) & Lukas Simon (Prinz’s Lab)
Moderators
Marie-Eve Trembley (University of Victoria, Canada) & Craig Moore (Memorial University of Newfoundland, Canada)

ASNI Neuroimmunology Seminar Series
2021-10-21 12:00 - 13:00 (America/New_York) | Virtual ASNI
Title: Neuroimmunology of CNS viral infections and cognitive sequelae
With
Robyn Klein (Washington University School of Medicine St. Louis, USA) & Sarah Rosen (Robyn’s Lab)
Moderators
Tajie Harris (University of Virginia, USA) & Ashley Mosen (Duke University, USA)

ESNI Journal Club
2021-10-26 16:00 - 17:00 (Europe/Rome) | Virtual ESNI
Title: A lymphocyte-microglia-astrocyte axis in chronic active multiple sclerosis
With
Martina Absinta (John Hopkins University School of Medicine, USA) & Daniel S. Reich (NIH Clinical Center, USA)
Presenting
Giulia Marostica (San Raffaele Hospital Milan, Italy)
Moderator
Maja Jagodic (Karolinska Institutet – Stockholm, Sweden)

Neuroimmunology Australia Webinar Series
2021-10-29 02:00 - 03:00 UTC | Virtual Neuroimmunology Australia
Dr Iain Comerford (University of Adelaide) – Title to be confirmed
Emina Hayashida (PhD student, USyd) – Title to be confirmed

15th ISNI Congress
2021-11-08 - 2021-11-12 | Virtual ISNI
Organizers:
Roland Liblau (Université Toulouse III Toulouse | France)
Sonia Berrih-Aknin (Sorbonne Université Paris | France)

Neuroimmunology Australia Webinar Series
2021-11-26 02:00 - 03:00 UTC | Virtual Neuroimmunology Australia
Dr Steven Petratos (Monash) – Targeted delivery of the NgR-Fc protein to enhance neurorepair in a model of multiple sclerosis
Dr John Lee (University of Queensland) – Title to be confirmed
